Acute Plasma Cell Leukemia Presenting as Primary Hyperammonemic Encephalopathy

Dveet Patel1,2, Andrew Mangano2, David Moccia2

  • 1Department of Internal Medicine, Grand Strand Health, Myrtle Beach, SC, USA.

Journal of Medical Cases
|August 26, 2021
PubMed

Insights

Primary plasma cell leukemia (PPCL), a rare aggressive multiple myeloma, can present atypically. This case highlights acute hyperammonemic encephalopathy as an unusual initial symptom of PPCL.

Area of Science:

  • Hematology
  • Oncology
  • Neurology

Background:

  • Primary plasma cell leukemia (PPCL) is an aggressive hematologic malignancy, a rare subtype of multiple myeloma (MM).
  • PPCL is characterized by a poor prognosis, with a median overall survival typically ranging from 6 to 11 months.
  • Early diagnosis and treatment are crucial for improving patient outcomes in aggressive cancers.

Observation:

  • A 78-year-old woman presented with acute hyperammonemic encephalopathy.
  • This neurological presentation was the first indication of an underlying disease process.
  • Diagnostic workup revealed the cause to be an undiagnosed case of primary plasma cell leukemia.

Findings:

  • The patient's acute hyperammonemic encephalopathy served as an atypical initial manifestation of PPCL.
  • This case underscores that neurological symptoms can be the presenting feature of this rare plasma cell disorder.
  • The findings emphasize the importance of considering hematologic malignancies in the differential diagnosis of unexplained encephalopathy.

Implications:

  • Recognizing atypical presentations of PPCL, such as hyperammonemic encephalopathy, can lead to earlier diagnosis and intervention.
  • This case expands the understanding of the clinical spectrum of primary plasma cell leukemia.
  • Highlighting rare initial symptoms can improve diagnostic strategies for aggressive hematologic cancers.